RESTASIS MULTIDOSE vs VYVGART

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. RESTASIS MULTIDOSE and VYVGART are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	RESTASIS MULTIDOSE	VYVGART
Rating	72/100	New
Pharmacy pays	~$52.85 /30	—
Type	RX	RX
Active ingredient	CYCLOSPORINE	EFGARTIGIMOD ALFA
Manufacturer	Abbvie	Argenx Bv
Dosage forms	Emulsion	Injectable
Drug class	Calcineurin Inhibitor Immunosuppressant	Neonatal Fc Receptor Blocker
Boxed warning	None	None
Half-life	about 8.4 hours (range 5 to 18 hours)	—
Treats	Rheumatoid Arthritis, Focal Segmental Glomerulosclerosis, Systemic Lupus Erythematosus	Myasthenia Gravis

restasis multidose vyvgart

Rating

72/100

New

Pharmacy pays

~$52.85 /30

—

Type

Active ingredient

CYCLOSPORINE

EFGARTIGIMOD ALFA

Manufacturer

Abbvie

Argenx Bv

Dosage forms

Emulsion

Injectable

Drug class

Calcineurin Inhibitor Immunosuppressant

Neonatal Fc Receptor Blocker

Boxed warning

None

Half-life

about 8.4 hours (range 5 to 18 hours)

—

Treats

Rheumatoid Arthritis, Focal Segmental Glomerulosclerosis, Systemic Lupus Erythematosus

Myasthenia Gravis

Frequently asked questions

What is the difference between Restasis Multidose and Vyvgart?

Restasis Multidose contains Cyclosporine, while Vyvgart contains Efgartigimod Alfa — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.